Data from clinical specimens demonstrate that high expression of mTORSer2448 phosphorylation and YAP are correlated with poor overall survival in patients with glioma and show a beneficial effect of dual targeting in vitro. The gene discussed is YAP1; the disease is central nervous system cancer.